1. Home
  2. OLN vs SRPT Comparison

OLN vs SRPT Comparison

Compare OLN & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olin Corporation

OLN

Olin Corporation

HOLD

Current Price

$25.04

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$15.22

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLN
SRPT
Founded
1892
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
OLN
SRPT
Price
$25.04
$15.22
Analyst Decision
Hold
Hold
Analyst Count
13
29
Target Price
$25.23
$25.85
AVG Volume (30 Days)
1.8M
2.6M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
2.92%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.88
Revenue
$6,780,800,000.00
$2,198,237,000.00
Revenue This Year
$2.57
N/A
Revenue Next Year
$3.51
N/A
P/E Ratio
N/A
$5.21
Revenue Growth
3.68
15.58
52 Week Low
$18.08
$10.42
52 Week High
$30.46
$25.32

Technical Indicators

Market Signals
Indicator
OLN
SRPT
Relative Strength Index (RSI) 44.21 34.08
Support Level $22.82 N/A
Resistance Level $26.84 $23.54
Average True Range (ATR) 0.85 0.73
MACD -0.09 -0.06
Stochastic Oscillator 41.51 15.56

Price Performance

Historical Comparison
OLN
SRPT

About OLN Olin Corporation

Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: